Company Profile
Zenlabs Ethica markets and distributes pharmaceutical products primarily in India. It markets analgesics and anti-inflammatory drugs. Its portfolio also includes skin preparations, drugs for neurological and GIT disorders, ear, eye, and nasal drops, anti-diabetic, anti-depressant, anti-infective, anti-emetic, anti-hypertensive, anti-allergic, and anti-cold and cough syrups, steroids and anabolic steroids, nutraceuticals, antacids, enzymes, and appetite stimulants, ayurvedic preparations, soaps, dusting powders, soaps, and pharmaceutical drugs.
The company is also involved in the private label manufacturing of various pharmaceutical products, such as tablets, capsules, injections, syrups, and ointments Therapeutics, such as anti-infective, anti-obesity, anti-bacterial, anti-hypertensives, anti-fungal, pain killers, and nutritional supplements.
The company serves customers through a network of distributors and stockists in Myanmar, Indonesia, Malaysia, Thailand, Cambodia, Vietnam, Laos, the Philippines, Singapore, Brunei, Timor-Leste, Bangladesh, and globally.
Formerly known as Neelkanth Technologies Limited, the company rebranded as Zenlabs Ethica Limited in January 2016. Zenlabs Ethica Limited was incorporated in 1993 and is based in Chandigarh, India.